Monitoring for CardioToxicity Using WeArable deVices While Undergoing cancEr Treatments (MCT-WAVE) | MicrobiomeTrials← Back to trialsNCT07776964
Monitoring for CardioToxicity Using WeArable deVices While Undergoing cancEr Treatments (MCT-WAVE)
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-09-15Est. Completion: 2028-03-01
Enrollment target: 72 participants Locations- M Health Fairview Clinics and Surgery Center, Minneapolis, Minnesota, United States
Other microbiome trials you might be interested in
Amyloidosis
The purpose of this study is to characterize cardiac safety of Daratumumab, Cyclophosphamide, Bortezomib, and Dexamethas…
Duarte, United StatesEst. completion Feb 4, 2026
Breast Cancer
Chemotherapy is an effective breast cancer treatment, which helped to increase the 5-year survival rate to approximately…
Gainesville, United StatesEst. completion Dec 2026